A key research output from SMARTbiomed will be software.
SMARTbiomed researchers will develop methods and software for analysing and interpreting health data, including causal inference (led by Erin Gabriel, University of Copenhagen), risk prediction (led by Bjarni Vilhjálmsson, Aarhus University), and machine learning (led by Chris Holmes, University of Oxford). SMARTbiomed will advance medical research, focusing on common complex diseases and disorders, especially cardiometabolic (diabetes, and cardiovascular diseases), brain (psychiatric and neurological), and reproductive (endometriosis, involuntary infertility) conditions.